Arvee Laboratories (India) Ltd. (NSE:ARVEE)

Market Cap	1.89B
Revenue (ttm)	353.65M
Net Income (ttm)	13.74M
Shares Out	11.02M
EPS (ttm)	1.24
PE Ratio	138.29
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	676
Average Volume	698
Open	167.00
Previous Close	171.85
Day's Range	167.00 - 178.00
52-Week Range	126.54 - 235.79
Beta	0.60
RSI	57.86
Earnings Date	Nov 13, 2025

About NSE:ARVEE

Arvee Laboratories (India) Ltd. manufactures and sells various specialized chemicals in India and internationally. The company offers polymer modifiers, including dimethyl 5-sodiosulfoisophthalate, 5-sulfoisophthalic acid mono sodium salt, 5-sulfoisophthalic acid mono lithium salt, and 5-sodiosulfo-bis-(ß-hydroxyethyl)-isophthalate; and contrast media intermediates, such as 5-nitroisophthalic acid, dimethyl 5-nitroisophthalate, monomethyl 5-nitroisophthalate, 5-hydroxyisophthalic acid, 5-aminoisophthalic acid, and dimethyl 5-aminoisophthalate, ...

• Industry: Specialty Chemicals
• Sector: Materials
• Founded: 2012
• Employees: 65
• Stock Exchange: National Stock Exchange of India
• Ticker Symbol: ARVEE

Financial Performance

In 2024, NSE:ARVEE's revenue was 384.87 million, an increase of 26.83% compared to the previous year's 303.45 million. Earnings were 21.47 million, an increase of 104.16%.